# Hunan Norchem Pharmaceutical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hunan-norchem-pharmaceutical-co

- Industry: Biotechnology
- Headquarters: Changde, China
- Website: www.norchem-pharma.com
- Latest round: Series B (Dec 15, 2023)
- Investors on record: 9

## About

Based in Changde, China, and founded in 2013, Hunan Norchem Pharmaceutical Co.,Ltd. operates as a pharmaceutical research and development manufacturer, focusing on steroid drug intermediates and APIs. The company also established more than 10 branch subsidiaries in Hunan, Beijing, Guangdong, and other places. It has also established two intermediate factories, a sex hormone API factory, and a formulation factory. Norchem has applied for 27 invention patents, 17 of which have been granted. In December 2023, the company closed pre-IPO funding.

Norchem is dedicated to the production of various pharmaceutical APIs and intermediates using biological fermentation and chemical synthesis with phytosterols as the starting material. The products of the company can be categorized into five categories which are betamethasone series, dexamethasone series, hydrocortisone series, prednisolone series, and progestin intermediates. Products within include betamethasone epoxide hydrolysate, dexamethasone epoxide hydrolysate acetate, hydrocortisone intermediate ester, prednisolone acetate, and acid decarboxylate.

## Funding rounds

- Series B, Dec 15, 2023 — OrbiMed Advisors, Cathay Capital, China International Capital Corporation, Zhonghe Capital, Changde Caixin Financial Holding Group, Hunan Xingxiang Investment Holding Group, Hunan Caixin Financial Holding Group, Hangzhou Xiaochi Private Equity Fund Management, A.D.Invest

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B
- Cathay Capital — Series B
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B
- Zhonghe Capital (https://capitalatlas.ai/funds/zhonghe-capital) — Series B
- Changde Caixin Financial Holding Group — Series B
- Hunan Xingxiang Investment Holding Group (https://capitalatlas.ai/funds/hunan-xingxiang-investment-holding-group) — Series B
- Hunan Caixin Financial Holding Group — Series B
- Hangzhou Xiaochi Private Equity Fund Management (https://capitalatlas.ai/funds/hangzhou-xiaochi-private-equity-fund-management) — Series B
- A.D.Invest — Series B